GKT137831
| CAS No. | 1218942-37-0 | Cat. No. | BCP14159 |
| Name | GKT137831 | ||
| Synonyms | GKT-137831;GKT 137831; GTK831; GTK-831; GTK 831;Setanaxib; | ||
| Formula | C21H19ClN4O2 | M. Wt | 394.85 |
| Description | GKT137831 is a novel and potent Nox4 inhibitor. GKT137831 reduced the increased leukocyte adherence to the vasculature, the pro-inflammatory phenotype of microglia and macroglia, the increased gene and protein expression of vascular endothelial growth factor, monocyte chemoattractant protein-1, and leukocyte adhesion molecules as well as vascular leakage. In all cultured cell types, GKT137831 reduced the hypoxia-induced increase in ROS levels and protein expression of various inflammatory mediators. GKT137831 may be potentially useful as a treatment for a variety of vision-threatening retinopathies. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | NOX | ||
|
Tert-butyl hydroperoxide (t-BHP) induced apoptosis and necroptosis in endothelial cells: Roles of NOX4 and mitochondrion
Publications Citing of Biochempartner's GKT137831(CAS:1218942-37-0) |
|
Danshenol A inhibits TNF-α-induced expression of intercellular adhesion molecule-1 (ICAM-1) mediated by NOX4 in endothelial cells
Publications Citing of Biochempartner's GKT137831(CAS:1218942-37-0) |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.